methylprednisolone has been researched along with Autoimmune Experimental Myasthenia Gravis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aricha, R; Feferman, T; Fuchs, S; Menon, RT; Souroujon, MC | 1 |
1 other study(ies) available for methylprednisolone and Autoimmune Experimental Myasthenia Gravis
| Article | Year |
|---|---|
Suppression of experimental autoimmune myasthenia gravis by combination therapy: pentoxifylline as a steroid-sparing agent.
Topics: Animals; Antibodies; Body Weight; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gene Expression Regulation; Glucocorticoids; Methylprednisolone; Muscle, Skeletal; Myasthenia Gravis, Autoimmune, Experimental; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Lew; Receptors, Cholinergic; Severity of Illness Index | 2008 |